Back to Neurology & Psychiatry (CNS)
Cerebroprotein Hydrolysate for Injection 60mg
Neurology & Psychiatry (CNS)

Cerebroprotein Hydrolysate for Injection 60mg

Pack Sizes Available

60mg vial with 10ml Sterile Water for Injection ampoule, box of 1
60mg vial, export tray pack

Product Description

Once a stroke or brain injury protocol calls for a more intensive dose, the 60mg strength of Cerebroprotein Hydrolysate for Injection is typically where treatment moves. It carries double the nitrogen-equivalent content of the 30mg presentation, and it is the strength most commonly reached for in adult patients undergoing active stroke rehabilitation, recovery from traumatic brain injury, or management of cognitive decline linked to neurodegenerative conditions such as Alzheimer's and Parkinson's disease. This is a peptide-based neurotrophic agent, derived from purified brain protein, that works by supporting the survival and repair of damaged neurons and encouraging the kind of synaptic plasticity the brain relies on during recovery from injury or progressive decline. It is not a standalone cure for any of these conditions, but it has become a well-established part of the broader treatment toolkit neurologists and rehabilitation specialists draw on, typically alongside physical therapy, cognitive rehabilitation, and other supportive care. Sara Wellness has built its export business over fifteen years around exactly this kind of specialized injectable, where fewer manufacturers compete and buyers need a partner who actually understands the product rather than a generic pharma trading house. We source this from GMP-certified Indian manufacturing facilities, and because it is a more technical product than a standard antibiotic, our team is equipped to answer detailed questions about composition, dosing protocols, and batch-to-batch consistency without deferring you to a separate technical department. We keep the relationship with every buyer direct, whether that is a rehabilitation hospital ordering for the first time or an established distributor managing supply across multiple neurology clinics in a region. Our minimum order quantities are structured to make a first trial order accessible without requiring the commitment of a full container, while still supporting the larger recurring orders that hospital networks with standing stroke protocols typically need. Every shipment ships with certificate of analysis, GMP compliance documentation, and export paperwork tailored to your destination country's regulatory requirements. If your hospital, rehabilitation center, or distribution business is building out a neurology and stroke recovery formulary and needs a dependable source for Cerebroprotein Hydrolysate, reach out with your target country and expected order size, and our team will respond with current pricing and realistic delivery timelines based on actual production schedules.

Technical Specifications

  • Active Ingredient: Cerebroprotein Hydrolysate approx. 2100mg, equivalent to 60mg Nitrogen per vial
  • Dosage Form: Sterile solution for injection
  • Drug Class: Neurotrophic peptide agent
  • Pack Configuration: Vial with 10ml Sterile Water for Injection USP ampoule
  • Route of Administration: Intramuscular or intravenous, as directed by physician
  • Storage Conditions: Store in a cool, dry place, protect from light
FAQ

Frequently asked questions

Contact Export TeamContact Export Team

It is used to support neurological recovery and cognitive function in patients dealing with stroke, traumatic brain injury, and cognitive decline associated with neurodegenerative conditions such as Alzheimer's and Parkinson's disease, by supporting neuron repair and protecting against further damage.

Each vial contains Cerebroprotein Hydrolysate approximately 2100mg, equivalent to 60mg nitrogen content, supplied with a 10ml ampoule of Sterile Water for Injection USP.

It is administered by intramuscular or intravenous route as directed by the treating physician, with the exact dosing schedule and duration determined by the patient's specific neurological condition and treatment protocol.

No, it is typically used as part of a broader treatment approach that includes physical therapy, cognitive rehabilitation, and other supportive medical care, rather than as a standalone cure.

Mild side effects such as dizziness, headache, or injection site discomfort have been reported, and patients should be monitored by their treating physician during the course of treatment.

Yes, we prepare certificate of analysis, GMP compliance certification, and other documentation required for import and product registration, tailored to the specific regulatory framework of your destination country.

You might also like

Related Products

Explore more high-quality items from our Neurology & Psychiatry (CNS) range.

Cerebroprotein Hydrolysate for Injection 30mg
Neurology & Psychiatry (CNS)

Cerebroprotein Hydrolysate for Injection 30mg

Recovery after a stroke or a serious head injury is rarely a straight line, and a lot of what neurologists are actually trying to do in those early weeks is give the brain's own repair mechanisms a better chance to work. Cerebroprotein Hydrolysate for Injection is built around that idea. It is a peptide-based neurotrophic agent derived from purified brain protein, used to support nerve cell recovery and protect neurons from further damage during acute and chronic brain-related conditions. The 30mg strength delivers a lower-nitrogen-equivalent dose commonly used in less severe cases, in pediatric and lower body weight patients, or as a starting dose in treatment protocols that scale up gradually. Clinically, this category of injectable is used across a range of neurological situations, including stroke rehabilitation, traumatic brain injury recovery, and cognitive decline associated with conditions like Alzheimer's disease, where supporting neuronal survival and synaptic function is part of the broader treatment strategy alongside physical and cognitive rehabilitation. For hospitals and neurology-focused clinics building out a rehabilitation and neuroprotection formulary, having a reliable, well-documented source for this category of injectable matters more than it might for a more commoditized product, simply because fewer manufacturers specialize in it. Sara Wellness has spent fifteen years building direct relationships with GMP-certified Indian manufacturers across a wide therapeutic range, including specialized neurology injectables like this one, and we bring the same documentation discipline to this product that we apply to our critical care antibiotic lines. We work one on one with hospital procurement teams, rehabilitation centers, and distributors rather than routing orders through intermediaries who add cost without adding value. That direct relationship matters particularly for a specialized neurology product, where questions about dosing protocols, batch consistency, and regulatory documentation tend to be more technical than a standard antibiotic order. Our MOQs are set to work for smaller neurology clinics testing this product for the first time as well as larger hospital networks incorporating it into standing stroke and brain injury protocols. Every shipment ships with certificate of analysis, GMP compliance documentation, and export paperwork prepared for your destination country's specific regulatory requirements. If your hospital, rehabilitation center, or distribution business is looking to add a dependable source for Cerebroprotein Hydrolysate to your neurology portfolio, reach out with your target country and expected order size and we will respond with current pricing and realistic delivery timelines.